000			02346 a2200685 4500
005			20250517083951.0
264		0	_c20170413
008			201704s 0 0 eng d
022			_a1097-6787
024	7		_a10.1016/j.jaad.2016.01.018 _2doi
040			_aNLM _beng _cNLM
100	1		_aFaivre, Coline
245	0	0	_aHidradenitis suppurativa (HS): An unrecognized paradoxical effect of biologic agents (BA) used in chronic inflammatory diseases. _h[electronic resource]
260			_bJournal of the American Academy of Dermatology _cJun 2016
300			_a1153-9 p. _bdigital
500			_aPublication Type: Journal Article; Multicenter Study
650	0	4	_aAdalimumab _xadverse effects
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAnti-Inflammatory Agents, Non-Steroidal _xadverse effects
650	0	4	_aAntibodies, Monoclonal, Humanized _xadverse effects
650	0	4	_aArthritis _xdrug therapy
650	0	4	_aBiological Products _xadverse effects
650	0	4	_aCrohn Disease _xchemically induced
650	0	4	_aDrug Eruptions _xetiology
650	0	4	_aDrug Substitution
650	0	4	_aEtanercept _xadverse effects
650	0	4	_aFemale
650	0	4	_aHidradenitis Suppurativa _xchemically induced
650	0	4	_aHumans
650	0	4	_aInfliximab _xadverse effects
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPsoriasis _xchemically induced
650	0	4	_aRecurrence
650	0	4	_aRetrospective Studies
650	0	4	_aRituximab _xadverse effects
650	0	4	_aWithholding Treatment
650	0	4	_aYoung Adult
700	1		_aVillani, Axel Patrice
700	1		_aAubin, François
700	1		_aLipsker, Dan
700	1		_aBottaro, Martine
700	1		_aCohen, Jean-David
700	1		_aDurupt, François
700	1		_aJeudy, Géraldine
700	1		_aSbidian, Emilie
700	1		_aToussirot, Eric
700	1		_aBadot, Valérie
700	1		_aBarbarot, Sébastien
700	1		_aDebarbieux, Sébastien
700	1		_aDelaporte, Emmanuel
700	1		_aGoegebeur, Guetty
700	1		_aMorel, Jacques
700	1		_aNassif, Aude
700	1		_aDuru, Gérard
700	1		_aJullien, Denis
773	0		_tJournal of the American Academy of Dermatology _gvol. 74 _gno. 6 _gp. 1153-9
856	4	0	_uhttps://doi.org/10.1016/j.jaad.2016.01.018 _zAvailable from publisher's website
999			_c25816487 _d25816487